{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:49:40Z","timestamp":1778539780598,"version":"3.51.4"},"reference-count":23,"publisher":"BMJ","issue":"2","funder":[{"name":"Channel 7 Telethon Foundation"},{"name":"The National Health Medical Research Council"},{"name":"The National Health Medical Research Council"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,12,7]]},"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Diarrhoeal disease is the second leading cause of death in children under 5 years globally, killing 525 000 annually. Australian Aboriginal and Torres Strait Islander (hereafter Aboriginal) children suffer a high burden of disease. Randomised trials in other populations suggest nitazoxanide accelerates recovery for children with\n                      <jats:italic>Giardia<\/jats:italic>\n                      , amoebiasis,\n                      <jats:italic>Cryptosporidium, Rotavirus and Norovirus<\/jats:italic>\n                      gastroenteritis, as well as in cases where no enteropathogens are found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This double blind, 1:1 randomised, placebo controlled trial is investigating the impact of oral nitazoxanide on acute gastroenteritis in hospitalised Australian Aboriginal children aged 3 months to &lt;5 years. Dosing is based on age-based dosing. The primary endpoint is the time to resolution of \u2018significant illness\u2019 defined as the time from randomisation to the time of clinical assessment as medically ready for discharge, or to the time of actual discharge from hospital, whichever occurs first. Secondary endpoints include duration of hospitalisation, symptom severity during the period of significant illness and following treatment, duration of rehydration and drug safety. Patients will be followed for medically significant events for 60 days. Analysis is based on Bayesian inference. Subgroup analysis will occur by pathogen type (bacteria, virus or parasite), rotavirus vaccination status, age and illness severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval has been granted by the Central Australian Human Research Ethics Committee (HREC-14\u2013221) and the Human Research Ethics Committee of the Northern Territory Department of Health and Menzies School of Health Research (HREC2014-2172). Study investigators will ensure that the trial is conducted in accordance with the principles of the Declaration of Helsinki. Individual participant consent will be obtained. Results will be disseminated via peer-reviewed publication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ACTRN12614000381684.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-019632","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T11:54:54Z","timestamp":1568894094000},"page":"e019632","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children"],"prefix":"10.1136","volume":"8","author":[{"given":"Claire S","family":"Waddington","sequence":"first","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Subiaco, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-7493","authenticated-orcid":false,"given":"Charlie","family":"McLeod","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Princess Margaret Hospital for Children, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Morris","sequence":"additional","affiliation":[{"name":"Menzies School of Health Research, Casuarina, Australia"},{"name":"Department of Paediatrics, Royal Darwin Hospital, Darwin, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Bowen","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Princess Margaret Hospital for Children, Perth, Australia"},{"name":"Menzies School of Health Research, Casuarina, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Naunton","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Canberra, Bruce, Canberra, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Subiaco, Australia"},{"name":"Infectious Diseases Department, Princess Margaret Hospital for Children, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Grimwood","sequence":"additional","affiliation":[{"name":"Queensland Children\u2019s Medical Research Institute, Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Robins-Browne","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl D","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Baird","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Royal Darwin Hospital, Darwin, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Alice Springs Hospital, Alice Springs, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Andrews","sequence":"additional","affiliation":[{"name":"Menzies School of Health Research, Casuarina, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Fearon","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Alice Springs Hospital, Alice Springs, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Francis","sequence":"additional","affiliation":[{"name":"Menzies School of Health Research, Casuarina, Australia"},{"name":"Department of Paediatrics, Royal Darwin Hospital, Darwin, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A","family":"Marsh","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Subiaco, Australia"},{"name":"Centre for Applied Statistics, University of Western Australia, Crawley, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Snelling","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Subiaco, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"2025121409075502000_8.2.e019632.1","unstructured":"World Health Organisation and UNICEF. The Integrated Global action plan for Pneumonia and Diarrhoea (GAPPD). 2013. http:\/\/apps.who.int\/iris\/bitstream\/10665\/79200\/1\/9789241505239_eng.pdf?ua=1 (accessed 13 Aug 2017)."},{"key":"2025121409075502000_8.2.e019632.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60844-2"},{"key":"2025121409075502000_8.2.e019632.3","unstructured":"Li SQ , Guthridge S , Tursan d\u2019Espaignet E , et al . From infancy to young adulthood: health status in the Northern Territory. Darwin: Department of Health and Community Services, 2006. http:\/\/digitallibrary.health.nt.gov.au\/dspace\/bitstream\/10137\/84\/1\/infancy_to_young_adulthood_2006.pdf (accessed 13 Aug 2017)."},{"key":"2025121409075502000_8.2.e019632.4","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.10062"},{"key":"2025121409075502000_8.2.e019632.5","first-page":"1","article-title":"Rotaviral gastroenteritis in the NT: a description of the epidemiology 1995-2001 and future directions for research","volume":"8","author":"Armstrong","year":"2001","journal-title":"Northern Territory Disease Control Bulletin"},{"key":"2025121409075502000_8.2.e019632.6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1440-1754.2006.00976.x","article-title":"Rotavirus outbreak in a remote Aboriginal community: the burden of disease","volume":"42","author":"Gelbart","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"2025121409075502000_8.2.e019632.7","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.590"},{"key":"2025121409075502000_8.2.e019632.8","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.61.707"},{"key":"2025121409075502000_8.2.e019632.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2011.11.007"},{"key":"2025121409075502000_8.2.e019632.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03033.x"},{"key":"2025121409075502000_8.2.e019632.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68852-1"},{"key":"2025121409075502000_8.2.e019632.12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cgh.2005.12.020","article-title":"Effect of nitazoxanide in diarrhea and enteritis caused by cryptosporidium species","volume":"4","author":"Rossignol","year":"2006","journal-title":"Clin Gastroenterol Hapatol"},{"key":"2025121409075502000_8.2.e019632.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2007.04.001"},{"key":"2025121409075502000_8.2.e019632.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2011.11.007"},{"key":"2025121409075502000_8.2.e019632.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03128.x"},{"key":"2025121409075502000_8.2.e019632.16","unstructured":"Department of Health. Northern Territory resident population estimates by age, sex, indigenous status and health districts (1971-2016)\u2019, prepared by health gains planning, file updated on 27 February 2017: ABS Estimated Resident Population, 2017."},{"key":"2025121409075502000_8.2.e019632.17","unstructured":"World Health Organization. The treatment of diarrhoea. 2005 http:\/\/whqlibdoc.who.int\/publications\/2005\/9241593180.pdf"},{"key":"2025121409075502000_8.2.e019632.18","first-page":"2759","article-title":"Nitazoxanide for the treatment of infectious diarrhoea in the Northern Territory, Australia 2007-2012","volume":"14","author":"McLeod","year":"2014","journal-title":"Rural Remote Health"},{"key":"2025121409075502000_8.2.e019632.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.09.014"},{"key":"2025121409075502000_8.2.e019632.20","doi-asserted-by":"publisher","DOI":"10.1179\/136485908X267894"},{"key":"2025121409075502000_8.2.e019632.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(02)90301-9"},{"key":"2025121409075502000_8.2.e019632.22","first-page":"219104","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"2025121409075502000_8.2.e019632.23","unstructured":"International Council for Harmonisation. Guidelines for good clinical practice, 2016. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R2__Step_4.pdf (accessed 4 Sep 2017)."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-019632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:08:04Z","timestamp":1765732084000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-019632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,1]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1136\/bmjopen-2017-019632"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-019632","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}